Harnessing endogenous peptide compounds as potential therapeutics for severe influenza.

West, Alison C; Harpur, Christopher M; Le Page, Mélanie A; Lam, Maggie; Hodges, Christopher; Ely, Lauren K; Gearing, Andrew J; Tate, Michelle D

West, Alison C; Harpur, Christopher M; Le Page, Mélanie A; Lam, Maggie; Hodges, Christopher; Ely, Lauren K; Gearing, Andrew J; Tate, Michelle D.

Afiliación

West AC; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Harpur CM; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
Le Page MA; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Lam M; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
Hodges C; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Ely LK; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
Gearing AJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Tate MD; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.

J Infect Dis ; 2023 Dec 07.

Article en En | MEDLINE | ID: mdl-38060822

Palabras clave

Influenza virus; cytokine; host-directed therapy; pulmonary disease

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google